Home
About
Overview
Sharing Data
ORCID
Help
History (12)
Delayed-release oral mesalamine 4.8 g/day (800 mg tablets) compared to 2.4 g/day (400 mg tablets) for the treatment of mildly to moderately active ulcerative colitis: The ASCEND I trial.
Circadian variation in ictus of aneurysmal subarachnoid hemorrhage.
Energy transfer and trapping in photosystem I reaction centers from cyanobacteria.
Challenges and strategies for generating therapeutic patient-specific hemangioblasts and hematopoietic stem cells from human pluripotent stem cells.
Controversies affecting the future practice of clinical microbiology.
See All 12 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Controversies affecting the future practice of clinical microbiology.
Controversies affecting the future practice of clinical microbiology. J Clin Microbiol. 1999 Apr; 37(4):883-9.
View in:
PubMed
subject areas
Cost-Benefit Analysis
Humans
Laboratories
Managed Care Programs
Microbiology
Point-of-Care Systems
United States